Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04313322

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:46.648169+00:00

Published At

2020-03-18T00:00:00+00:00

Record Updated At

2020-03-18

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Use of Stem Cells for COVID-19 Treatment"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2020-03-18"

protocolSection.identificationModule.nctId

"NCT04313322"

protocolSection.identificationModule.officialTitle

"Treatment of COVID-19 Patients Using Wharton\u0027s Jelly-Mesenchymal Stem Cells"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Use of Stem Cells for COVID-19 Treatment (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.